INTERLEUKIN-1 ALPHA STIMULATES HEMATOPOIESIS BUT NOT TUMOR-CELL PROLIFERATION AND PROTECTS MICE FROM LETHAL TOTAL-BODY IRRADIATION

被引:19
作者
CONSTINE, LS [1 ]
HARWELL, S [1 ]
KENG, P [1 ]
LEE, F [1 ]
RUBIN, P [1 ]
SIEMANN, D [1 ]
机构
[1] UNIV ROCHESTER, MED CTR, DEPT EXPTL THERAPEUT, ROCHESTER, NY 14642 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1991年 / 20卷 / 03期
关键词
RADIOPROTECTION; INTERLEUKIN-1; GROWTH FACTORS;
D O I
10.1016/0360-3016(91)90056-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interleukin 1 alpha (IL-1) is a polypeptide/glycoprotein growth factor with multiple functions including the modulation of hematopoietic cell proliferation and differentiation. In vivo studies were performed with C57BL/6J mice injected with 0, 0.02, or 2.0-mu-g of IL-1 24 hr before or after lethal total body irradiation (TBI) (9.5 Gy). More mice in the groups administered IL-1 before TBI survived (90% of the 2.0-mu-g group) than those treated 2 or 24 hr after TBI, which was still slightly superior to the uninjected group, which all died within 15 days (p = .0001). Proliferation of bone marrow granulocyte/macrophage colonies following split dose TBI was also greatest for mouse groups treated with IL-1 prior to TBI. These experiments support data from other investigators that IL-1 stimulation of BM is related to IL-1 timing with respect to TBI. Stimulation of hemopoiesis was also assessed in terms of changes in peripheral blood and BM cell numbers and cell cycle kinetics using an electronic particle counter and flow cytometric techniques. Mice injected with 2-mu-g of IL-1 showed an initial decline (at 3-6 hr) and then a selective proliferation (24-48 hr) of early and more committed progenitor cells to 125% and 200% of control values, respectively. Peripheral blood counts rose accordingly. Cells in S and G2/M phases increased over 10 hr and then declined in number. It thus appeared that some synchronization of cell cycling occurred, which might place cells in a more radioresistant phase of the cell cycle. The glutathione (GSH) content and synthesis in BM cells were measured by isocratic paired-ion high performance liquid chromatography and S-35-lavelled cysteine incorporation into the GSH tripeptide. An increase in cellular GSH content and synthesis was demonstrated following IL-1 which lasted 24 hr, suggeting a possible mechanism for the radioprotection by IL-1. To determine the potential for achieving a favorable therapeutic ratio, KHT tumor-bearing mice were injected with 2.0-mu-g IL-1. No change in tumor diameters or weights or tumor cell clonogenicity between IL-1 treated or untreated animals was observed. These experiments strongly support a role for IL-1 in stimulating bone marrow to overcome the myelosuppressive effects of irradiation.
引用
收藏
页码:447 / 456
页数:10
相关论文
共 47 条
[1]  
ANDREEFF M, 1989, SEMIN ONCOL, V16, P211
[2]  
ARRICK BA, 1984, CANCER RES, V44, P4224
[3]   INTERLEUKIN-1 STIMULATES GRANULOCYTE MACROPHAGE COLONY-STIMULATING ACTIVITY RELEASE BY VASCULAR ENDOTHELIAL-CELLS [J].
BAGBY, GC ;
DINARELLO, CA ;
WALLACE, P ;
WAGNER, C ;
HEFENEIDER, S ;
MCCALL, E .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1316-1323
[4]   RADIOSENSITIZATION, THIOL OXIDATION, AND INHIBITION OF DNA-REPAIR BY SR-4077 [J].
BAKER, MA ;
TAYLOR, YC ;
BROWN, JM .
RADIATION RESEARCH, 1988, 113 (02) :346-355
[5]   SYNERGISM BETWEEN HEMATOPOIETIC GROWTH-FACTORS (HGFS) DETECTED BY THEIR EFFECTS ON CELLS BEARING RECEPTORS FOR A LINEAGE SPECIFIC HGF - ASSAY OF HEMOPOIETIN-1 [J].
BARTELMEZ, SH ;
STANLEY, ER .
JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 122 (03) :370-378
[6]  
BENJAMIN WR, 1989, J IMMUNOL, V142, P792
[7]  
BOT FJ, 1990, BLOOD, V76, P307
[8]  
BUBENIK J, 1988, FOLIA BIOL-PRAGUE, V34, P42
[9]   ROLE OF GLUTATHIONE IN THE RADIATION RESPONSE OF MAMMALIAN-CELLS INVITRO AND INVIVO [J].
BUMP, EA ;
BROWN, JM .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) :117-136
[10]  
CASTELLI MP, 1988, J IMMUNOL, V140, P3830